(Q57003964)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

ORCID Public Data File 2021

author name string

A Altimari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Fiorentino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Gabusi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Gruppioni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Corti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A D'Errico

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W F Grigioni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

332-338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma: global epidemiology

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Nonsurgical treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

The EGFR as a target for anticancer therapy--focus on cetuximab

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Role of EGF receptor tyrosine kinase activity in antiapoptotic effect of EGF on mouse hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900077-X

7 January 2021

10.1016/S1590-8658(03)00077-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference